Royal Bank Of Canada Merrimack Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Nov 05, 2024	BUY	$13.06 - $15.0 $5,681 - $6,525	435 New	435 $6,000
Q1 2024 May 15, 2024	SELL	$13.06 - $15.0 $39,872 - $45,795	-3,053 Reduced 87.53%	435 $6,000
Q4 2023 Feb 14, 2024	BUY	$12.02 - $13.41 $25,806 - $28,791	2,147 Added 160.1%	3,488 $46,000
Q3 2023 Nov 14, 2023	BUY	$11.6 - $12.52 $997 - $1,076	86 Added 6.85%	1,341 $16,000
Q2 2023 Aug 14, 2023	BUY	$12.02 - $13.07 $14,988 - $16,298	1,247 Added 15587.5%	1,255 $15,000
Q4 2022 Feb 14, 2023	SELL	$3.68 - $12.51 $12,994 - $44,172	-3,531 Reduced 99.77%	8 $0
Q3 2022 Nov 14, 2022	BUY	$3.7 - $6.06 $114 - $187	31 Added 0.88%	3,539 $13,000
Q1 2022 May 16, 2022	SELL	$3.75 - $6.82 $33 - $61	-9 Reduced 0.26%	3,508 $22,000
Q4 2021 Feb 14, 2022	BUY	$3.75 - $5.1 $5,658 - $7,695	1,509 Added 75.15%	3,517 $14,000
Q2 2021 Aug 16, 2021	BUY	$6.04 - $7.77 $12,128 - $15,602	2,008 New	2,008 $13,000

Others Institutions Holding MACK

# of Institutions

1

Shares Held

77

Call Options Held

0

Put Options Held

0

Farther Finance Advisors, LLC San Francisco, CA

77
Shares

$1,165
0.0% of portfolio

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.